Literature DB >> 6259945

Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.

M C Dal Canto, S G Rabinowitz.   

Abstract

Temperature-sensitive (ts) mutants of viruses may represent an important mechanism for viral persistence. Ts mutants of different complementation groups of vesicular stomatitus virus (VSV) have shown various disease patterns in infected mice which were at variance with the clinical and pathologic features of wild-type virus infection. To investigate whether neurovirulence of different ts mutants was dependent on the individual mutant or on the biochemical defect(s) common to all members of a complementation group, we infected mice with ts G32 VSV, a mutant of the same complementation group III as the previously described ts G31 VSV. Pathologic changes in infected mice were sharply different from those produced by ts G31 VSV and actually similar to those produced by ts G41 VSV, a member of Complementation Group IV, also previously described. These results suggest that the biologic behavior of ts mutants is dependent on the individual characteristics of each mutant. The most important alterations by ts G32 VSV were in the white matter of brain and spinal cord, where extensive inflammatory demyelination was observed. Lack of inflammation and demyelination in similarly infected nude mice would suggest that, in this infection, demyelination is produced by the host immune response rather than by direct viral myelinolytic activity. Such findings are similar to those we described in other viral infections and support the hypothesis of a common host-mediated pathway leading to demyelination in a variety of unrelated viral infections. These conclusions may have relevance to human demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259945      PMCID: PMC1903723     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Preliminary physiological characterization of temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  C R Pringle; I B Duncan
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

2.  Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy.

Authors:  B N Fields; C S Raine; S G Baum
Journal:  Virology       Date:  1971-03       Impact factor: 3.616

3.  Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins.

Authors:  P Printz; R R Wagner
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

4.  Physiological characterization of heat-defective (temperature-sensitive) poliovirus mutants: preliminary classification.

Authors:  P D Cooper; R T Johnson; D J Garwes
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

5.  Observations on viral demyelinating encephalomyelitis. Canine distemper.

Authors:  H Wiśniewski; C S Raine; W J Kay
Journal:  Lab Invest       Date:  1972-05       Impact factor: 5.662

6.  Temperature-sensitive mutants of respiratory syncytial virus.

Authors:  M A Gharpure; P F Wright; R M Chanock
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

7.  Semliki forest virus temperature-sensitive mutants: isolation and characterization.

Authors:  K B Tan; J F Sambrook; A J Bellett
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

8.  Temperature-sensitive mutants of influenza A virus: isolation of mutants and preliminary observations on genetic recombination and complementation.

Authors:  R W Simpson; G K Hirst
Journal:  Virology       Date:  1968-05       Impact factor: 3.616

9.  Isolation and characterization of conditional-lethal mutants of Sindbis virus.

Authors:  B W Burge; E R Pfefferkorn
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The genetics of vesiculoviruses.

Authors:  C R Pringle
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein.

Authors:  Anthony N van den Pol; Kevin P Dalton; John K Rose
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.

Authors:  S Sriram; D J Topham; S K Huang; M Rodriguez
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.

Authors:  B S Huneycutt; Z Bi; C J Aoki; C S Reiss
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Comparative neurovirulence of selected vesicular stomatitis virus temperature-sensitive mutants of complementation groups II and III.

Authors:  S G Rabinowitz; J Huprikar; M C Dal Canto
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

Review 6.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

Review 7.  Acute disseminated encephalomyelitis: clinical and pathogenesis features.

Authors:  Farshid Noorbakhsh; Richard T Johnson; Derek Emery; Christopher Power
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

Review 8.  Experimental models of virus-induced demyelination of the central nervous system.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

9.  Marek's disease virus-induced transient paralysis in chickens: electron microscopic lesions.

Authors:  J N Kornegay; E J Gorgacz
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.